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Background:  Identiﬁed  in  2001,  Human  Metapneumovirus  (HMPV)  is  a Pneumovirus  associated  with
acute  lower  and upper  respiratory  infections  in  all  age  groups  and  especially  in  newborns,  elderly  and
immunocompromised  subjects.  Data  are  still  limited  in  sub-Saharan  African  countries  genetic  character-
ization  of this  respiratory  virus.  This  study  reports  the genetic  variability  of  HMPV  strains  in Cameroonian
children  for  3 consecutive  epidemic  seasons  (September  2011–October  2014).
Methods: A prospective  surveillance  was  conducted  to identify  inpatient  and  outpatient  children  less
than  15  years  with  respiratory  symptoms  ≤5  days.  The  nasopharyngeal  samples  were  tested  for  HMPV
using  a multiplex  polymerase  chain  reaction.  Viral  distribution  and  demographic  data  were analyzed
statistically.  Positive  samples  for HMPV  were  ampliﬁed  by semi-nested  polymerize  chain  reaction  and
then partially  sequenced  at the  G  gene.  Phylogenetic  analyzes  were  performed  on  the  partial  nucleotide
and  protein  sequences  of the  G gene.
Results:  From  September  2011  to October  2014,  822  children  under  15 years  were  enrolled  in  the  study.
HMPV  was  identiﬁed  in each  of  3.9%  (32/822)  of children.  HMPV  were  detected  throughout  the year.
HMPV-A  (73.3%;  11/15)  was  predominant  compared  to HMPV-B  (26.7;  4/15).  Cameroonian  HMPV  strains
are  grouped  among  the  members  of  genotype  A2b  (for  HMPV-A),  B1 and  B2  (for HMPV-B).
Conclusion:  This  study  suggests  that about  4% of ARI  recorded  in children  in Cameroon  are  caused  by
HMPV.  The  present  study  is  also  the  ﬁrst  report  on  the  genetic  variability  of the  G gene  of  HMPV  strains
in  the  region.  Although  this  work  partially  ﬁlls  gaps  for some  information,  additional  studies  are  required
to  clarify  the molecular  epidemiology  and  evolutionary  pattern  of  HMPV  in  sub-Saharan  Africa  in  general
and more  particularly  in  Cameroon.
© 2019  The  Authors.  Published  by Elsevier  Limited  on  behalf  of King  Saud  Bin Abdulaziz  University
for  Health  Sciences.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://ntroductionPlease cite this article in press as: Kenmoe S, et al. Phylogenetic variabil
infections in Cameroon, 2011–2014. J Infect Public Health (2019), http
Human Metapneumovirus (HMPV), ﬁrst identiﬁed in the
etherlands in 2001 [1], is an important causative agent of acute
espiratory infections worldwide in susceptible individuals, partic-
Abbreviations: HMPV, Human Metapneumovirus.
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ularly children, adults and immunocompromised patients [2]. This
virus accounts for 6.24% (95% CI 5.25–7.30) of hospitalized patients
with acute respiratory tract infections [3]. Since its identiﬁcation,
HMPV has been identiﬁed in many countries across ﬁve continents,
including Africa [4–9]. This virus causes annual epidemics in late
winter and early spring in temperate regions, while in subtropi-
cal regions it peaks in spring and summer [4–6,10]. HMPV is an
enveloped virus with a genome consisting of a single-stranded and
non-segmented RNA molecule approximately 13 kb in length [1].ity of Human Metapneumovirus in patients with acute respiratory
s://doi.org/10.1016/j.jiph.2019.08.018
This genome contains eight genes that code for 9 different proteins
in the order 3′-NPMF-M2-1/M2-2-SH-GL-5′. With the exception
of the M2  gene, which has two overlapping open reading frames,
all other genes have a single open reading frame. The viral enve-
n Abdulaziz University for Health Sciences. This is an open access article under the
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ope contains three transmembrane surface glycoproteins in the
orm of 13–17 nm projections, the highly glycosylated attachment
lycoprotein G, the fusion protein F and the small hydrophobic pro-
ein SH [11]. F and G proteins promote binding, membrane fusion
nd viral penetration into the host cell cytoplasm [12]. These two
roteins are also the main antigenic determinants that stimulate
he neutralizing antibody response. Protein F is relatively con-
erved while G has the greatest genetic and antigenic variability
5,13,14]. Taxonomically, the HMPV belongs to the Pneumoviridae
amily and Pneumovirinae sub-family. Genetically, its closest rel-
tive is the Avian Pneumovirus Type C with whom HMPV shares
he closest relationship with respect to sequence identity and gene
onstellation. Based on the analysis of the entire genome or other
enes, HMPV was divided into two distinct genotypes A and B and
ubdivided into four subgenotypes A1, A2, B1 and B2 [1,13,15].
ubgenotype A2 was further classiﬁed into two categories A2a and
2b [15]. Although this classiﬁcation is consistent independently
f the gene studied, the great genetic and antigenic variability
etween them is mainly found on the surface gene G [5,13–15],
hereas the other genes are much more conserved [16,17]. The
ynamics and history of HMPV evolution have been studied thanks
o the advent of a large number of HMPV sequences in databases.
nlike other paramyxoviruses, the four HMPV genetic genotypes
ave been preserved over time because the gene sequences, like
he G and F genes, do not display signiﬁcant progressive genetic
rift [18]. In this respect, the G gene has strongly conserved motifs
n its ectodomain. Multiple studies have helped to show that the
 HMPV subgroups can cocirculate simultaneously with the pre-
ominance of one of the subgroups and alternation of the majority
enotype from year to year [4,10,13–15]. It is also well under-
tood that the different lineages can circulate simultaneously in the
ame place during a given season [5,19–23]. The importance of this
ighly variable and complex circulation model remains, however,
till largely uncertain in sub-Saharan Africa. Despite its importance
s a respiratory pathogen, information on molecular characteriza-
ion of HMPV from sub-Saharan African countries remains limited
9]. Repeated HMPV infections during life are common and there
s currently no effective vaccine [24,25]. The possibility of reinfec-
ion with HMPV could be a challenge in developing a future HMPV
accine. This reinfection could be either because of incomplete
mmunity or genetic changes of the virus. For the development
f vaccines, a thorough understanding of the genetic and anti-
enic heterogeneity of HMPV transmembrane glycoproteins from
ll origins is therefore necessary. In Cameroon, we have previously
eported HMPV circulation among 4% hospitalized children and
% ambulatory patients with acute respiratory infections [26,27].
n this study, we examine the extent of genetic variability of
he HMPV G gene in Yaounde, Cameroon for three consecutive
ears.
aterial and methods
esign of the study
This work is a cross-sectional study that was  conducted for
 years from September 2011 to October 2014. The participants
ere recruited from the Centre Hospitalier d’Essos, Yaoundé,
ameroon. Yaounde is one of the most populous city of the
ameroonian state with about 2.8 million inhabitants. This city isPlease cite this article in press as: Kenmoe S, et al. Phylogenetic variabil
infections in Cameroon, 2011–2014. J Infect Public Health (2019), http
ocated in the Central region and is covered by an equatorial cli-
ate with alternating two dry seasons (mid-November to early
arch and mid-June to early September) and two rainy seasons
early March to mid-June and early September to mid-November). PRESS
 Public Health xxx (2019) xxx–xxx
Inclusion criteria
The study was done by a non-probability sampling and a con-
secutive recruitment. The subjects included in the survey were
children under 15 years who were outpatients or hospitalized and
consulted for acute respiratory tract infections. Ambulatory par-
ticipants were eligible if they had a sudden-onset fever with a
temperature >38 ◦C less than 5 days with cough and/or sore throat.
Inpatients consisted of individuals with the above criteria in addi-
tion to hospitalization. Children whose parents or guardians did not
give their consent for the study were not included.
Ethical considerations
Samples were submitted to the Pasteur Center of Cameroon as
part of the IMMI  project I¨nstitute of Microbiology and Infectious
Diseases.¨ The procedures of the original study (IMMI  project) were
evaluated and approved by the National Research Ethics Committee
and the Ministry of Public Health of Cameroon (authorization N◦
121/CNE/SE/2011). Written informed consent was obtained from
the parents or guardians of the children recruited in the study. A
numerical code has been assigned to all included individuals and
no conﬁdential participant data has been disclosed in this work.
HMPV detection
A nasopharyngeal swab was  collected either at the time of con-
sultation or after hospitalization. The sample was placed in a tube
containing 1 mL  of viral transport medium, transported in cool-
ers in the laboratory, and stored at −80 ◦C until analysis. The viral
RNA was extracted using QIAamp Viral RNA Mini kit and QIAamp
DNA Mini kit and according to the manufacturer’s recommenda-
tions (Qiagen, Hilden, Germany). The extracted RNA were screened
for HMPV using a commercially Respiratory Multi Well System r-
geneTM (bioMerieux, Lyon, France) as previously described [28].
HMPV genotyping
The HMPV-positive samples were ampliﬁed by a conventional
RT-PCR targeting G gene [13,14]. The RT-PCR reaction was car-
ried out using the SuperScript® III One-Step RT-PCR System kit
according to the manufacturer’s instructions (Thermo Fisher Sci-
entiﬁc, Carlsbad, CA, USA). Brieﬂy, 5 L of RNA was added to
a 45 L PCR reaction mixture containing 16 L of water, 25 L
of 2X reaction mix, 1 L of forward primer HMPVG Fwd (5′-
GAGAACATTCGRRCRATAGAYATG-3′) at 10 M,  1 L of reverse
primer HMPVG Rev (5′-AGATAGACATTRACAGTGGATTCA-3′) at
10 M,  and 2 L of Platinum® Taq DNA Polymerase. The
HMPVG Fwd primer corresponds to position 6262–6285 and the
HMPVG Rev primer to nucleotides 7181–7204 of the reference
sequence 001 (Genbank number: AF371337). The thermal pro-
ﬁle used consisted of a reverse transcription at 55 ◦C for 30 min,
a denaturation step at 94 ◦C for 2 min; followed by 40 cycles at
94 ◦C for 15 s, 55 ◦C for 30 s and 68 ◦C for one minute; and a ﬁnal
extension at 68 ◦C for 5 min. Genotyping PCR ampliﬁcation products
were sequenced bidirectionally using BigDye Terminator v3.1 Cycle
Sequencing kit (Thermo Fisher Scientiﬁc, Foster City, CA, USA). The
primers used for sequencing were the same as those used for geno-
typing RT-PCR.
Phylogenetic analysisity of Human Metapneumovirus in patients with acute respiratory
s://doi.org/10.1016/j.jiph.2019.08.018
The forward and reverse sequences were edited and assembled
into a single consensus. Peaks of poor quality at the sequences
extremities were removed. The predicted nucleotide sequences
were translated into protein sequence. The consensus sequences
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Table  1
General data of the study participants.
Characteristics Total Human metapneumovirus
No (822) Negative 790 (96.1) Positive 32 (3.9)
Gender
Male 437 (53.2) 423 (53.5) 14 (43.8)
Female 384 (46.7) 366 (46.3) 18 (56.3)
NA  1 (0.1) 1 (0.1)
p-Value 0.3
Age
[0–6] months 102 (12.5) 99 (12.5) 3 (9.4)
[6–24] months 413 (50.6) 394 (49.9) 19 (59.4)
[2–5] years 210 (25.7) 203 (25.7) 7 (21.9)
[5–15] years 92 (11.3) 90 (11.4) 2 (6.3)
NA 5 (0.6) 4 (0.5) 1 (3.1)
p-Value 0.6
Patients
Inpatients 436 (53) 419 (53.0) 17 (53.1)
Outpatients 386 (47) 371 (47.0) 15 (46.9)
p-Value 1
Symptoms
Cough 691 (84.1) 664 (83.6) 27 (96.4)
Rhinorrhea 660 (80.3) 637 (80.2) 23 (82.1)
Fatigue 475 (57.8) 456 (57.4) 19 (67.9)
Wheezing 295 (35.9) 281 (35.4) 14 (50)
Breathlessness 170 (20.7) 161 (20.3) 9 (32.1)
Diarrhea 168 (20.4) 161 (20.3) 7 (25)
Vomiting 252 (30.7) 243 (30.6) 9 (32.1)
Cutaneous rash 58 (7.1) 54 (6.8) 4 (14.3)
Conjunctivitis 85 (10.3) 82 (10.3) 3 (10.7)
Sore throat 140 (17.0) 137 (17.3) 3 (10.7)
Headache 102 (12.4) 100 (12.6) 2 (7.1)
Arthralgia 47 (5.7) 45 (5.7) 2 (7.1)
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A: not available. Data are number (%).
f this study as well as reference sequences from other countries
round the world were aligned using the CLUSTAL W algorithm
29]. The comparison of similarity proportions was  performed
etween our isolates and the HMPV- A2 reference strains (Gen-
ank No. AY296021), HMPV- B1 (Genbank No. AY296034) and
MPV-B2 (Genbank No. AY296040). The phylogenetic tree was
onstructed using the Maximum Likelihood method and under
he best model of evolution that was Tamura Nei with a Gamma
istribution. The robustness of the tree was evaluated with 1000 re-
ampling bootstrap. Potentially N- and O-glycosylated sites were
redicted using NetNGlyc version 1.0 and NetOGlyc version 4.0
nline servers respectively [30]. Sequences were assembled and
dited using the EDITSEQ program in the SeqmanTM II Lasergene
oftware (DNA, Madison, WI,  USA) and phylogenetic analyzes were
erformed using the MEGA Version 6 software [31]. The nucleotide
equences of this study were submitted to GenBank and recorded
ith accession numbers MK050259 to MK050273.
tatistical analysis
The data was analyzed using the R software version 3.4.1. Quan-
itative variables were presented as median and interquartile range
IQR). Categorical variables were expressed in numbers and pro-
ortions. The analysis assessed the potential associated risk factors
sex, age, and severity) for HMPV infections using the Pearson’s
hi-square independence test with a signiﬁcance level of less than
%.
esults
tudy populationPlease cite this article in press as: Kenmoe S, et al. Phylogenetic variabil
infections in Cameroon, 2011–2014. J Infect Public Health (2019), http
A total of 822 children were recruited between September 2011
nd October 2014. The median age of study participants was 19
onths IQR [9–36]. The age of the patients ranged from 1 month23 (2.9) 1 (3.6)
31 (3.9) 1 (3.6)
to 15 years. Of the 822 children recruited, 12.5% were less than 6
months, 50.6% between 6 and 24 months, 25.7% between 2 and 5
years, and 11.3% between 5 and 15 years. The study included 437
(53.2%) boys and 384 (46.7%) girls, a sex ratio of 1.1 (437/384). Of
the children, 436 (53%) were hospitalized while 386 (47%) were
ambulatory.
Viral detection
HMPV was  detected in 32 (3.9%, 95% CI 2.6–5.4%) of the 822
analyzed samples. The most common symptoms were cough,
rhinorrhea, fatigue and wheezing (Table 1). Sex, age, and inpa-
tient/outpatient status of children were not associated with HMPV
infections. In 2012 and 2013 HMPV was detected almost through-
out the year while no cases in 2011 and two  sporadic cases in 2014
were detected.
HMPV genotyping
To differentiate the HMPV-positive samples, an 870 nucleotide
fragment of the G gene was  ampliﬁed for 15/30 (50%) tested sam-
ples. Half of the samples could not be ampliﬁed. The viral load
of the unampliﬁed samples was signiﬁcantly lower than that of
the ampliﬁed ones (33.3; IQR [31.7–35.1] vs 23.9; IQR [21.5–27.6];
p < 0.01). The partial G genes of all ampliﬁed HMPV were sequenced
successfully.
Molecular epidemiology
Groups A (11) and B (4) of the HMPV were detected in 2012ity of Human Metapneumovirus in patients with acute respiratory
s://doi.org/10.1016/j.jiph.2019.08.018
and 2013 with a predominance of Group A in 2013 (10/12, 81.8%).
Sporadic cases of subgroup HMPV-A2b (1), B2 (2) were detected in
2012. The year 2013 revealed one case of HMPV-B1 and one case of
HMPV-B2. Cameroonian HMPV isolates, based on 467 bp of the G
Please cite this article in press as: Kenmoe S, et al. Phylogenetic variability of Human Metapneumovirus in patients with acute respiratory
infections in Cameroon, 2011–2014. J Infect Public Health (2019), https://doi.org/10.1016/j.jiph.2019.08.018
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Fig. 1. Phylogenetic tree of HMPV-A and HMPV-B strains detected in Yaoundé, Cameroon from 2011 to 2013.
Multiple sequence alignment was performed with Clustal W.  The rooted tree was generated based on G gene nucleotide sequences (467 nucleotides of position 6397–6864 of
reference sequence 00-1 Genbank number AF371337) using the maximum likelihood method and the best model evolution (Tamura Nei) with a discrete gamma  distribution
in  Mega 6. The numbers on the nodes of the branches are determined values for resampling bootstrap after 1000 iterations. Only values greater than or equal to 70% are
presented. The reference sequences of different continents, obtained on Genbank, are identiﬁed from the left to the right with the access number, the name of the strain, the
origin  country and the genotype attributed by the author. The strains of the current study are designated from left to right by CMR  (Cameroon), the year of detection and the
laboratory number. Cameroon sequences are shown with () and () for the 2012 and 2013 sequences, respectively.
 ING ModelJ
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ene, were grouped into three monophyletic branches, HMPV-A2b
11), B1 (1) and B2 (3) with reference strains from other countries
Fig. 1). No speciﬁc branch of time or space was observed.
ucleotide and protein polymorphism
The description of the amino acid sequences deduced from the
ameroonian HMPV-A2b, HMPV-B1 and HMPV-B2 strains was car-
ied out with reference to the partial sequence of the G genes of the
L/17/00 prototypes (AY296021, 190 residues: positions 31–221),
L/1/99 (AY296034, 209 residues: positions 25–233) and NL/1/94
AY296040, 218 residues: positions 25–243), respectively. The G
enes of the Cameroonian HMPV-A2b, HMPV-B1 and HMPV-B2
iruses had divergence rates ranging from 12.3 to 15%; 6.1%; and 6.2
o 6.8% at the nucleotide level and 23.4 to 26.9%; 15.5%; and 10.2 to
2.5% at the amino acid level, respectively. Transitions were most
ommon than transversions for all HMPV Cameroonian sequences
ith a transition/transversion ratio of 7, 25, and 7.8 for HMPV-A2b,
MPV-B1 and HMPV-B2, respectively. The partial G gene sequences
f the HMPV-A2b, HMPV-B1 and HMPV-B2 strains were aligned
ith sequences from other countries of the world and reference
equences (Supplementary Fig. 1A–C).
The Cameroon strains of genotype A2b, B1 and B2 had a length
f 190, 208 and 217 amino acids, respectively. S90N, I151R and
155S substitutions were shared by all Cameroonian HMPV-A2b
equences and sequences from other countries. The substitutions
99T, Y133H, Y197N and R198G were shared by all Cameroonian
MPV-B2 sequences and sequences from other countries. An inser-
ion of 4 amino acids was observed at position 160 of the HMPV-B2
enotype.
lycosylation proﬁle
Potential N-glycosylation sites were observed on the G protein
equences of the study (Supplementary Fig. 1A–C). An amino acid
equence of subgroup HMPV-A2b had a potential N-glycosylation
ite at position 52-54. Three potential N-glycosylation sites at
ositions 101–103, 169–171 and 188–190 were identiﬁed on
he HMPV-B1 sequence of this study. For the G proteins of the
MPV-B2 subgroup, three potential N-glycosylation sites were
dentiﬁed, amino acids 68-60, 180–182 and 183-185. Mutations in
he sequences of this study also led to gains or losses of poten-
ial N-glycosylation sites. In total, three additional N-glycosylation
ites were present on some Cameroonian strains HMPV-A2b amino
cids 105–107 (1/10), 131–133 (3/10) and 140–142 (3/10). The
equences of the study had lost potential N-glycosylation sites
t amino acid positions 88–90 and 101–103 for HMPV-A2b and
81–183 for HMPV-B1. The number of serine and threonine
esidues, probably O-glycosylated ranged from 52 to 60, 59 and
3 to 64 for the HMPV-A2b, B1 and B2 sequences of the study
espectively.
iscussion
During this study, we determined the epidemiology and car-
ied out for the ﬁrst time the molecular characterization of the
ucleotide sequence and amino acid predicted of the partial G gene
f HMPV isolated in nasopharyngeal swab of Cameroonian chil-
ren from September 2011 to October 2014 at Yaoundé, Capital of
ameroon.
HMPV was identiﬁed in 3.9% of the samples tested. This fre-
uency of detection corresponds to those we previously reported inPlease cite this article in press as: Kenmoe S, et al. Phylogenetic variabil
infections in Cameroon, 2011–2014. J Infect Public Health (2019), http
ameroon and those reported by other authors in Africa [7,9,26,27].
s in previous reports, there was no difference in infection rates
etween age groups (p = 0.6) [32]. Indeed, studies have shown that
nfections occur in all age groups probably due to partial immune PRESS
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protection or the acquisition of new genotypes [9,33]. Unlike the
study by Wang et al. where the majority of positive HMPV partic-
ipants were hospitalized, there was  no difference between HMPV
infection and hospitalization in this study [4]. In temperate regions,
HMPV infections are distributed mainly in late winter and early
spring [6,10]. Some studies, however, have shown that HMPV can
be detected throughout the year [34]. To create more confusion
some studies have shown that HMPV also circulates in summer
[4,5]. Long-term studies have also shown a pattern of biennial cir-
culation with low and high positive rates in odd and even years [6].
In addition, the peak of HMPV activity has been shown to vary by
year in some studies [5]. There is very little data on the seasonality
of HMPV in the tropical countries. For this study we are unable to
clearly argue on HMPV seasonality because of the very low number
of positive samples detected. However, in agreement with other
tropical countries, the peaks of circulation were observed dur-
ing the rainy season (September to December) [14]. Therefore, to
elucidate the circulation pattern of HMPV in Cameroon, further,
longer-term studies are warranted. As reported in other studies
[8,9,20,33], 50% (15/30) of the HMPV positives were not ampliﬁed
by RT-PCR for sequencing. This result could be due to a low viral
load in unampliﬁed samples. Indeed the viral load the unampliﬁed
samples were signiﬁcantly lower than that of the ampliﬁed ones.
Previous data has shown that two  or more subgroups of HMPV can
co-circulate in regions where HMPV is endemic [6,14,19–23,35].
Phylogenetic analysis of the partial G gene sequences in this study
demonstrates the cocirculation in Cameroon of the two  HMPV-A
and B groups divided into three subgroups A2b, B1 and B2 during
the study period. These three genotypes have also been reported
in studies in Kenya and South Africa [13,9]. Similar to the pre-
vious studies [14], the HMPV-A1 genotype that were detected
during the years 2000–2003 [13,16], were not identiﬁed in this
study. The HMPV-A group is predominant in the HMPV-B group
in most studies [36,37]. Similarly to these studies, of the 15 HMPV
isolates of this study, 11 (73.3%) were grouped as HMPV-A (A2b
sub group) and 4 (26.7%) strains were grouped as HMPV-B (3 B2
and 1 B1). As in the current study, HMPV-A group, subgroup A2b
was more frequently detected in other studies [36,38]. Phyloge-
netic analysis have shown that subgroups of the HMPV virus are
neither temporally nor spatially limited and are randomly dis-
tributed over the years and in different countries [39]. The data
also showed that HMPV subgroups co-circulate with replacement
of dominant subgroups every 1–3 years [6]. This alternate in the
model of domination in HMPV groups may be due to the develop-
ment of community immunity in response to dominant group from
year to year. This complex pattern of HMPV circulation poses a real
challenge for the development of a future vaccine. Very few studies
have reported the distribution of HMPV subgroups in sub-Saharan
Africa [9,22]. In this study, HMPV-A2b (1) and HMPV-B2 (2) were
identiﬁed in 2012. In addition to one HMPV-B2 detected in 2013,
a high increase in HMPV-A2b (10) and a case of HMPV-B1 have
been highlighted. We  must be cautious when interpreting on the
variations of HMPV subgroups in Cameroon. Indeed, although three
subgroups of HMPV were detected in this study, only 50% (15/30)
of HMPV-positive samples were characterized from unrepresenta-
tive sampling. Therefore, it is impossible to say whether this would
represent the pattern of alternation or predominance of HMPV
subgroups in Cameroon during the study period. It is therefore nec-
essary to conduct long-term studies in Cameroon in order to clarify
the HMPV circulation pattern. As observed in previous studies [19],
the G proteins of Cameroon subgroup B2 viruses had a length dif-
ferent from the reference strain. This longer length was attributedity of Human Metapneumovirus in patients with acute respiratory
s://doi.org/10.1016/j.jiph.2019.08.018
to an insertion of 12 additional nucleotides in the Cameroonian G
sequences. The mutations S90N, I151R and N155S were present
in all Cameroonian sequences, as observed in previous studies
[13,14]. As previously reported [14,18,19], N52 glycosylation sites
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or HMPV-A2b (4/10); N101, N169 and N188 for HMPV-B1; N58,
180 and N183 for HMPV-B2 were observed in the Cameroonian
equences. Compared to the reference sequence (NL/17/00) [40],
he Cameroonian sequences lost the N-glycosylation sites N88 and
101 and acquired 3 additional sites N105 (1/11), N131 (3/11) and
140 (3/10). In addition, the B1 sequence of this study lost the N181
-glycosylation site observed in the reference strain [40].
Our study is, however, have several limitations. The collection
f clinical data, the potential risk factors (malnutrition, immunode-
ression, congestion), and the outcome of included patients were
ot exhaustive. As a result, assessment of the burden, risk fac-
ors and pathogenicity of HMPV infections in Cameroon remains
ncomplete.
onclusion
In conclusion, this is the ﬁrst study in Cameroon to characterize
MPV-A and B in hospitalized and ambulatory pediatric patients
or a 3 year consecutive period. In addition, the results acquired
n the current study also provide for the ﬁrst time data on HMPV
enotypes detected in Cameroon. Genetic characterization of G gly-
oprotein, the main target of many vaccines under development,
ndicated that three HMPV subgroups (A2, B1 and B2) were iden-
iﬁed during the study. This study highlights the importance of
mplementing other large-scale studies based on the general popu-
ation in resource-limited countries like Cameroon where data are
till very scarce.
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